Bank of Montreal vs McKesson Corporation — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while McKesson Corporation trades at $801.49 (market cap $95.10B). The key difference: Bank of Montreal is the larger of the two by market cap, and Bank of Montreal pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| BMO | MCK | |
|---|---|---|
Market Cap | $124.81B | $95.10B |
Sector | Financials | Health |
52-Week High | $180.86 | $995.69 |
52-Week Low | $110.44 | $659.01 |
Dividend Yield | 2.77% | 0.4% |
Enterprise Value | — | $99.74B |
Trailing returns across standard periods
Latest headlines on both assets
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →